JT
MNPR icon

Jupiter Topco’s Monopar Therapeutics MNPR Stock Holding History

Jupiter Topco’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122M Buy
+1,312,129
New +$81.2M 0.05% 281

Other funds holding MNPR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Jupiter Topco's MNPR Position: Q2 2026 in Review

Jupiter Topco opened a new position in Monopar Therapeutics (MNPR) in Q2 2026: 1,312,129 shares worth $122M. The stake represents 0.05% of the portfolio and ranks #281 among its holdings.

85 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Jupiter Topco held 1,312,129 shares of Monopar Therapeutics worth $122M as of Q2 2026.
  • Monopar Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Monopar Therapeutics made up 0.05% of Jupiter Topco's portfolio in Q2 2026, its #281 holding.
  • 85 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.